EUVIMEDEUVIMED entdecken
Open Access

Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales

Mustafa Sadek iD, Juan Bosch Duran, Laurent Poirel iD, Patrice Nordmann iD

Antimicrobial Agents and Chemotherapy · 17.05.2023 · 67 (5)

DOI: 10.1128/aac.00078-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 17.05.2023. Verfasst von Mustafa Sadek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Lactams. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Fribourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The in vitro activity of imipenem-relebactam, meropenem-vaborbactam, ceftazidime-avibactam, and cefiderocol was evaluated against both clinical and isogenic enterobacterial isolates producing carbapenemases of the SME, NmcA, FRI, and IMI types. Ceftazidime-avibactam and meropenem-vaborbactam showed the highest activity against all tested isolates; imipenem-relebactam showed only moderate activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamase InhibitorsLactamsMeropenemAnti-Bacterial AgentsCeftazidimeAzabicyclo Compoundsbeta-LactamasesImipenemDrug CombinationsMicrobial Sensitivity TestsCefiderocolBoronic AcidsBacterial Proteins

Stichwörter der Autor:innen

EnterobacteralesFRINMC-ASMEcarbapenemaseimipenem-relebactamminor carbapenemases

Substanzen

beta-Lactamase InhibitorsMeropenemLactamsAnti-Bacterial AgentsCeftazidimeAzabicyclo Compoundsbeta-LactamasesImipenemDrug CombinationsCefiderocol

Autor:innen und Institutionen

  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
  • Institute for Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland.

ORCID-Profile: Mustafa Sadek, Laurent Poirel, Patrice Nordmann

Förderung

  • University of Fribourg

Zitieren

APA

Sadek, M., Bosch Duran, J., Poirel, L., & Nordmann, P. (2023). Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales. Antimicrobial Agents and Chemotherapy, 67(5). https://doi.org/10.1128/aac.00078-23

Vancouver

Sadek M, Bosch Duran J, Poirel L, Nordmann P. Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales. Antimicrobial Agents and Chemotherapy. 2023;67(5). doi:10.1128/aac.00078-23

BibTeX
@article{Sadek2023,
  author = {Sadek, Mustafa and Bosch Duran, Juan and Poirel, Laurent and Nordmann, Patrice},
  title = {Impact of Minor Carbapenemases on Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {5},
  doi = {10.1128/aac.00078-23}
}
Kostenlos starten →